• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[法国的透析费用]

[Cost of dialysis in France].

作者信息

Benain Jean-Philippe, Faller Bernadette, Briat Claude, Jacquelinet Christian, Brami Michèle, Aoustin Martine, Dubois Jean-Pierre, Rieu Philippe, Behaghel Cecile, Duru Gérard

机构信息

JNB-Développement, 6, rue du Général-Larminat, 75015 Paris, France.

出版信息

Nephrol Ther. 2007 Jun;3(3):96-106. doi: 10.1016/j.nephro.2007.03.001. Epub 2007 May 11.

DOI:10.1016/j.nephro.2007.03.001
PMID:17540311
Abstract

The provision of care for patients with end-stage chronic renal failure is an important medical and economic challenge for the Health Insurance. Previous studies have shown a lower cost for home dialysis. More recently, studies have confirmed identical short-term survival rates between haemodialysis and peritoneal dialysis. Notwithstanding, home dialysis techniques utilization remains weak in France. This work aims at: determining the average annual cost of dialysis, per patient and per technique of dialysis, and assessing the global annual cost of dialysis in France, from the Health Insurance perspective. Methodologically, this article provides a static estimation of the cost of dialysis. Costs related to co-morbidities of end-stage chronic renal failure have not been considered. Standard patient care schemes have been outlined by a multidisciplinary expert committee, for each dialysis technique, and have been valorised using publicly available data and tariffs recorded in 2005. Our result show that home dialysis techniques are the less costly, with an average annual cost per patient of 49.9, 49.7 and 50.0 k euro respectively for home haemodialysis, automated peritoneal dialysis, and continuous ambulatory peritoneal dialysis. Autodialysis, autonomous in-center haemodialysis and in-center haemodialysis respectively cost 59.5, 62.3 and 81.5 k euro per patient and per annum. The total 2005 cost of dialysis for the Health Insurance is estimated at 2.1 billion euro. Therefore, the development of alternative techniques to in-center haemodialysis, such as home dialysis or autonomous in-center haemodialysis, autodialysis being already well developed, could generate savings for the Health Insurance. From the patient's perspective, it could also allow the enlightened choice of the best customized technique, less guided by local offer than by medical or social criteria, as well as by the patient's own opinion.

摘要

为终末期慢性肾衰竭患者提供护理,对医疗保险来说是一项重大的医疗和经济挑战。此前的研究表明,家庭透析成本较低。最近,研究证实血液透析和腹膜透析的短期生存率相同。尽管如此,家庭透析技术在法国的利用率仍然很低。这项工作旨在:从医疗保险的角度,确定每位患者每种透析技术的平均年度透析成本,并评估法国透析的全球年度成本。在方法上,本文提供了透析成本的静态估计。未考虑终末期慢性肾衰竭合并症的相关成本。一个多学科专家委员会针对每种透析技术制定了标准患者护理方案,并使用2005年记录的公开可用数据和收费标准进行了评估。我们的结果表明,家庭透析技术成本较低,家庭血液透析、自动化腹膜透析和持续性非卧床腹膜透析每位患者的平均年度成本分别为49.9、49.7和50.0千欧元。自我透析、自主中心血液透析和中心血液透析每位患者每年的成本分别为59.5、62.3和81.5千欧元。2005年医疗保险的透析总成本估计为21亿欧元。因此,开发中心血液透析的替代技术,如家庭透析或自主中心血液透析(自我透析已经得到充分发展),可为医疗保险节省开支。从患者的角度来看,这也可以让患者根据医学或社会标准以及自己的意见,更明智地选择最适合自己的技术,而较少受到当地医疗服务的限制。

相似文献

1
[Cost of dialysis in France].[法国的透析费用]
Nephrol Ther. 2007 Jun;3(3):96-106. doi: 10.1016/j.nephro.2007.03.001. Epub 2007 May 11.
2
Economic evaluation of dialysis therapies.透析疗法的经济学评估。
Semin Nephrol. 2009 Sep;29(5):524-32. doi: 10.1016/j.semnephrol.2009.06.009.
3
The financial implications for Medicare of greater use of peritoneal dialysis.更多使用腹膜透析对医疗保险的财务影响。
Clin Ther. 2009 Apr;31(4):880-8. doi: 10.1016/j.clinthera.2009.04.004.
4
[The cost of dialysis and kidney transplantation in France in 2007, impact of an increase of peritoneal dialysis and transplantation].[2007年法国透析和肾脏移植的费用,腹膜透析和移植增加的影响]
Nephrol Ther. 2010 Jul;6(4):240-7. doi: 10.1016/j.nephro.2010.04.005. Epub 2010 May 31.
5
A cost effectiveness analysis of the treatment of end stage renal failure.终末期肾衰竭治疗的成本效益分析
N Z Med J. 1990 Apr 25;103(888):171-4.
6
The economic cost of dialysis: a comparison between peritoneal dialysis and in-center hemodialysis in a Spanish unit.透析的经济成本:西班牙一家医疗机构中腹膜透析与中心血液透析的比较
Adv Perit Dial. 1996;12:93-6.
7
Cost analysis of dialysis treatments for end-stage renal disease (ESRD).终末期肾病(ESRD)透析治疗的成本分析。
Clin Invest Med. 1995 Dec;18(6):455-64.
8
Cost analysis and health-related quality of life of home and self-care satellite haemodialysis.家庭与自我护理卫星血液透析的成本分析及健康相关生活质量
Nephrol Dial Transplant. 2008 Jun;23(6):1990-6. doi: 10.1093/ndt/gfm910. Epub 2008 Jan 26.
9
[Epidemiologic aspects of terminal chronic kidney failure and its therapeutic modalities].[终末期慢性肾衰竭的流行病学特征及其治疗方式]
Prog Urol. 1996 Oct;6(5):683-5.
10
Reducing hemodialysis costs: conventional and quotidian home hemodialysis in Canada.降低血液透析成本:加拿大的传统和日常家庭血液透析
Semin Dial. 2004 Mar-Apr;17(2):118-24. doi: 10.1111/j.0894-0959.2004.17208.x.

引用本文的文献

1
Burden level and quality of life of caregivers of hemodialysis patient's in central India: a mixed-method cross-sectional study.印度中部血液透析患者照料者的负担水平与生活质量:一项混合方法横断面研究。
BMC Res Notes. 2025 Jul 15;18(1):291. doi: 10.1186/s13104-025-07374-1.
2
Home versus in-centre haemodialysis for people with kidney failure.居家透析与中心透析治疗肾衰竭患者的效果比较。
Cochrane Database Syst Rev. 2024 Apr 8;4(4):CD009535. doi: 10.1002/14651858.CD009535.pub3.
3
Is the cost of the new home dialysis techniques still advantageous compared to in-center hemodialysis? An Italian single center analysis and comparison with experiences from western countries.
与中心血液透析相比,新型家庭透析技术的成本是否仍然具有优势?一项意大利单中心分析及与西方国家经验的比较。
Front Med (Lausanne). 2024 Mar 11;11:1345506. doi: 10.3389/fmed.2024.1345506. eCollection 2024.
4
The direct cost of dialysis supported by families for patients with chronic renal failure in Ouagadougou (Burkina Faso).家庭为支持在瓦加杜古(布基纳法索)的慢性肾衰竭患者进行透析所承担的直接费用。
BMC Nephrol. 2022 Jun 23;23(1):222. doi: 10.1186/s12882-022-02847-y.
5
Unmet needs for CKD care: from the general population to the CKD clinics-how many patients are we missing?慢性肾脏病护理未满足的需求:从普通人群到慢性肾脏病诊所——我们遗漏了多少患者?
Clin Kidney J. 2021 Mar 12;14(10):2246-2254. doi: 10.1093/ckj/sfab055. eCollection 2021 Oct.
6
'A sword of Damocles': patient and caregiver beliefs, attitudes and perspectives on presymptomatic testing for autosomal dominant polycystic kidney disease: a focus group study.“达摩克利斯之剑”:常染色体显性遗传多囊肾病(ADPKD)症状前检测的患者和照护者信念、态度和观点:一项焦点小组研究。
BMJ Open. 2020 Oct 10;10(10):e038005. doi: 10.1136/bmjopen-2020-038005.
7
Effects of educational practices on the peritonitis risk in peritoneal dialysis: a retrospective cohort study with data from the French peritoneal Dialysis registry (RDPLF).教育实践对腹膜透析患者腹膜炎风险的影响:一项来自法国腹膜透析登记处(RDPLF)数据的回顾性队列研究。
BMC Nephrol. 2020 May 29;21(1):205. doi: 10.1186/s12882-020-01867-w.
8
Educating end-stage renal disease patients on dialysis modality selection.对终末期肾病患者进行透析方式选择方面的教育。
NDT Plus. 2010 Jun;3(3):225-233. doi: 10.1093/ndtplus/sfq059. Epub 2010 Apr 16.
9
A comprehensive approach to assess the costs of renal replacement therapy for end-stage renal disease in France: the importance of age, diabetes status, and clinical events.评估法国终末期肾病肾脏替代治疗成本的综合方法:年龄、糖尿病状态和临床事件的重要性
Eur J Health Econ. 2017 May;18(4):459-469. doi: 10.1007/s10198-016-0801-6. Epub 2016 May 5.
10
Caregiver burden and hemodialysis.照顾者负担与血液透析
Clin J Am Soc Nephrol. 2014 May;9(5):840-2. doi: 10.2215/CJN.02690314. Epub 2014 Apr 10.